| HBS Case Collection
(Revised from original version)
Novo Industri A/S--1981
This small but rapidly growing Danish biochemical company must choose among several financing opportunities that include a convertible Eurobond, a rights offering in Denmark and an issue of new common shares in the United States. The case involves a broad range of issues concerning the ability of a multinational company to lower its cost of capital by tapping different capital markets worldwide.
Keywords: Capital Markets;
Cost of Capital;
Financing and Loans;
Kester, W. Carl, and Glynn Ferguson. "Novo Industri A/S--1981." Harvard Business School Case 286-084, November 1992. (Revised from original February 1986 version.)